Download OU M.Pharma Ph.Analysis 1st Sem 2019 13160 PCI Advanced Pharmaceutical Analysis Question Paper

Download OU (Osmania University) M.Pharma-Ph.Analysis (Master of Pharmacy) 1st Sem 2019 13160 PCI Advanced Pharmaceutical Analysis Previous Question Paper

We rely on ads to keep our content free. Please consider disabling your ad blocker or whitelisting our site. Thank you for your support!


- -
Code No. 13160 / PCI
FACULTY OF PHARMACY
M. Pharmacy (Phar.Analysi.) I ? Semester (PCI) (Main & Backlog) Examination,
January 2019
Subject: Advanced Pharmaceutical Analysis
Time: 3 Hrs Max.Marks: 75
Note: Answer any five questions. All questions carry equal marks.
1 a) Define Impurity and give the classification of impurities in new drug substances. 5
b) Explain the guidelines for reporting and control of elemental impurities in new drug
products. 10
2 a) Describe the FDA/ICH guidelines for reporting levels of impurities in residual
solvents. 10
b) Write short note on qualification of degradation products. 5
3 a) Explain the factors affecting stability of drug substance and drug products. 10
b) How do y perform photo stability of formulations? 5
4 a) Write abt differe nt analytical techniques used in characterization of degradants. 10
b) What is impurity profiling and give its importance in testing of pharmaceutical
products. 5
5 a) Write abt HPTLC as finger printing tool in stability te sting of phytopharma
ceuticals. 10
b) What are accelerated stability studies and how do y calculate shelf life of drug
products. 5
6 Write abt the following
a) Enzyme immunoassay 8
b) Optical Immunoassay 7
7 a) Describe the principle and procedure involved in the biological assay of oxytocin. 8
b) What are antitoxins? Give biological assay of Tetanus antitoxin. 7
8 a) Discuss the different polymerase chain reaction studies for gene expression. 8
b) Explain the different steps involved in production of antibodies. 7
****



FirstRanker.com - FirstRanker's Choice

This post was last modified on 19 July 2020